Fig. 2From: Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patientsA–C Top 20 VIP metabolites (A) and lipids (B) from the PLS-DA model. C Pathway enrichment analysis, including the metabolites differentially expressed in patients with HCC, HCV and MC. The red dot colour intensity on the x-axis reflects the P value; the dot size axis represents the enrichment ratio weightBack to article page